Top 50 Medical VC Funds & Investors in Middle East (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
OurCrowd
VC Fund
|
19 | Israel, United States, New Zealand | Series B, Series A, Seed | Software, Artificial Intelligence, Health Care | $593k–$62M |
|
Pontifax
VC Fund
|
11 | United States, Israel, France | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.3M–$130M |
|
Israel Innovation Authority
VC Fund
|
10 | Israel, United States, Mali | Grant, Seed, Pre-Seed | Health Care, Artificial Intelligence, Biotechnology | $100k–$6M |
|
Trendlines Group
VC Fund
|
9 | Israel, Singapore, United Kingdom | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $650k–$62M |
|
HIMAngel
VC Fund
|
7 | Egypt, Saudi Arabia, United States | Seed, Pre-Seed, Convertible Note | Food and Beverage, E-Commerce, Agriculture | $100k–$860k |
|
F6 Ventures
VC Fund
|
6 | Egypt, United Arab Emirates, Saudi Arabia | Pre-Seed, Seed, Non-Equity Assistance | Software, E-Commerce, Information Technology | $15k–$1.1M |
|
Diffusion Capital Partners
VC Fund
|
6 | Turkey, United States, United Kingdom | Seed, Pre-Seed | Software, Information Technology, SaaS | $59k–$3M |
|
HBL Hadasit Bio Holdings
VC Fund
|
6 | Israel | Venture - Series Unknown, Seed, Series A | Biotechnology, Medical, Health Care | $10M–$47M |
|
Cybele Holdings
VC Fund
|
6 | Israel, United States, Cyprus | Post-IPO Equity, Venture - Series Unknown, Series D | Health Care, Real Estate, Biotechnology | $524k–$98M |
|
Triventures
VC Fund
|
6 | United States, Israel, Ireland | Series B, Venture - Series Unknown, Series A | Health Care, Medical Device, Medical | $3.6M–$28M |
|
Alesta Yatırım
VC Fund
|
6 | Turkey, United States, Estonia | Seed, Pre-Seed, Convertible Note | Software, Artificial Intelligence, Information Technology | $26k–$4.6M |
|
Alumni Ventures
VC Fund
|
6 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Artificial Intelligence, Health Care | $850k–$75M |
|
Qatar Development Bank
VC Fund
|
6 | Qatar, United States, United Arab Emirates | Seed, Pre-Seed, Venture - Series Unknown | Artificial Intelligence, Software, Financial Services | $52k–$3M |
|
Endure Capital
VC Fund
|
5 | Egypt, United States, United Kingdom | Seed, Series A, Series B | Software, Health Care, E-Commerce | $120k–$42M |
|
Docor International Management
VC Fund
|
4 | Israel, United States | Series C, Venture - Series Unknown | Health Care, Biotechnology, Medical Device | $8M–$22M |
|
S2G Investments
VC Fund
|
4 | United States, Canada, Israel | Series A, Series B, Venture - Series Unknown | Food and Beverage, Agriculture, Biotechnology | $3.9M–$100M |
|
aMoon Fund
VC Fund
|
4 | United States, Israel, France | Series B, Series A, Series C | Health Care, Biotechnology, Medical | $5.7M–$93M |
|
Agriline
VC Fund
|
4 | Israel | Seed, Series A, Venture - Series Unknown | Health Care, Medical, Biotechnology | $1.3M–$17M |
|
Elron Ventures
VC Fund
|
4 | Israel, United States, China | Series A, Seed | Information Technology, Software, Cyber Security | $1M–$17M |
|
Btomorrow Ventures
VC Fund
|
4 | United States, United Kingdom, India | Series A, Seed, Series B | Health Care, Wellness, Food and Beverage | |
|
Vertex Ventures Israel
VC Fund
|
4 | Israel, United States, Canada | Series A, Series B, Series C | Software, Information Technology, Artificial Intelligence | $3.5M–$100M |
|
Terra Venture Partners
VC Fund
|
3 | Israel, United States | Seed, Series A, Series B | Software, Health Care, Machine Learning | $1M–$30M |
|
Robin Hood Ventures
VC Fund
|
3 | United States, Canada, Israel | Seed, Series A, Convertible Note | Software, Health Care, Biotechnology | $26k–$11M |
|
Tal Ventures
VC Fund
|
3 | Israel, United States, Cyprus | Seed, Series A, Pre-Seed | Software, Artificial Intelligence, SaaS | $2.1M–$25M |
|
Clal Biotechnology Industries
VC Fund
|
3 | Israel, United States | Series A, Series B | Health Care, Biotechnology, Medical Device | $4M–$55M |
|
Mindset Ventures
VC Fund
|
3 | United States, Israel, Canada | Series A, Seed, Series B | Software, Artificial Intelligence, Machine Learning | $1.9M–$35M |
|
TechWald Holding S.p.A.
VC Fund
|
3 | Israel, United States, Switzerland | Series A, Series B, Series C | Health Care, Medical Device, Medical | $3.6M–$60M |
|
Accelmed
VC Fund
|
3 | United States, Israel | Series D, Series A | Health Care, Medical Device, Medical | $695k–$96M |
|
Husam
VC Fund
|
3 | Qatar | Seed, Pre-Seed | Medical, Health Care | $1.2M–$1.8M |
|
XTX Ventures
VC Fund
|
3 | United Kingdom, United States, Israel | Series A, Seed, Series B | Artificial Intelligence, Software, Machine Learning | $2M–$200M |
|
Speed Accelerator
VC Fund
|
3 | Lebanon, United Arab Emirates, United States | Seed, Pre-Seed | E-Commerce, Apps, Internet | $30k–$500k |
|
Alon Medtech Ventures
VC Fund
|
3 | Israel, United States | Seed, Venture - Series Unknown, Series B | Health Care, Medical, Medical Device | $900k–$2.2M |
|
EISMEA
VC Fund
|
3 | Spain, Italy, United Kingdom | Grant, Venture - Series Unknown, Seed | Manufacturing, Biotechnology, Software | $52k–$2.6M |
|
Insight Partners
VC Fund
|
3 | United States, Israel, Germany | Series B, Series A, Series C | Software, Artificial Intelligence, SaaS | $12M–$150M |
|
Acibadem University
VC Fund
|
3 | Turkey | Seed | Medical, Health Care, Medical Device | |
|
Neo Ventures
VC Fund
|
3 | United States, United Kingdom, Israel | Seed, Series A | Software, Artificial Intelligence, SaaS | $500k–$24M |
|
Ziegler Meditech Equity Partners
VC Fund
|
3 | United States, Israel | Series C, Series E, Series F | Health Care, Biotechnology, Mobile | |
|
A15
VC Fund
|
3 | Egypt, United States, United Kingdom | Seed, Venture - Series Unknown, Pre-Seed | E-Commerce, FinTech, Software | $50k–$8M |
|
Good Company
VC Fund
|
3 | Israel, United States | Seed, Pre-Seed, Series A | Software, Artificial Intelligence, Recruiting | $400k–$22M |
|
OrbiMed
VC Fund
|
3 | United States, China, Israel | Series B, Series A, Series C | Biotechnology, Health Care, Pharmaceutical | $9.8M–$160M |
|
GE Ventures
VC Fund
|
3 | United States, Israel, Canada | Series B, Series A, Series C | Health Care, Software, Enterprise Software | $6M–$70M |
|
ALIVE Israel HealthTech Fund
VC Fund
|
3 | Israel, United States | Series A, Series B, Series C | Health Care, Biotechnology, Medical Device | $4.4M–$55M |
|
Phoenician VC
VC Fund
|
3 | Lebanon, United Arab Emirates, Egypt | Seed, Series A, Pre-Seed | FinTech, Financial Services, Software | $50k–$8.4M |
|
ShengJing360
VC Fund
|
3 | China, Israel, Malaysia | Series A, Series B, Seed | Artificial Intelligence, Manufacturing, Biotechnology | $2M–$120M |
|
Qure Ventures
VC Fund
|
3 | United States, Israel | Series A, Series B, Series C | Health Care, Medical Device, Medical | $8.8M–$20M |
|
Connecticut Innovations
VC Fund
|
3 | United States, Israel, Canada | Seed, Series A, Series B | Health Care, Biotechnology, Software | $150k–$75M |
|
CE Ventures (CEIIF)
VC Fund
|
3 | Israel, United States, India | Series B, Series A, Series C | Software, Analytics, Big Data | $3.5M–$40M |
|
MTIP AG
VC Fund
|
3 | United States, United Kingdom, Spain | Series A, Series B, Series C | Health Care, Medical, Artificial Intelligence | $1.5M–$80M |
|
AUC Angels
VC Fund
|
3 | Egypt, United Kingdom, United States | Seed, Pre-Seed, Angel | E-Commerce, Software, Retail | $40k–$1.2M |
|
Entrée Capital
VC Fund
|
3 | Israel, United States, United Kingdom | Seed, Series A, Series B | Software, FinTech, Financial Services | $1.5M–$54M |
| Access all 50 VC funds in Middle East Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Invest in exclusive and pre-vetted startups, late-stage companies, and top tier funds - private market access made simple, transparent, and institutional-grade.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series B, Series A, Seed
- Geography: Israel, United States, New Zealand
Investor stats
- Total investments: 387
- Round size: Seed $593k–$8M; Series A $3M–$22M; Series B $6.3M–$62M
- Lead/follow: 16% lead, 84% follow
- Last fund: Likely actively investing — fresh fund, raised $230k in 2026
Portfolio highlights
- N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
- Hemispheric — Hemispheric develops fundamental AI technologies aimed at deciphering brain activity for innovative applications.
- MUV Interactive — MUV Interactive designs and develops innovative technology for active human sensing, providing a natural and fluent interactive experience with any type of digital application, from displayed content, and smart home appliances to IOT (Internet of Things) devices, drones and AR/VR applications. The company’s flagship product, Bird, is anintuitive device that is worn on the index finger, which transforms any space into a 3D Interactive Environment. Bird is the first device to integrate the entire spectrum of input and control methods – including touch, remote touch, gesture control and mouse functionality. This gives users the flexibility to interact with each type of digital content in the most intuitive way, whether up close or from a distance of up to 100 feet away.
Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 122
- Round size: Series A $6.3M–$110M; Series B $20M–$130M; Series C $22M–$101M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — raised $14M in 2020
Portfolio highlights
- Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
- Crystalys Therapeutics — Transforming care for people living with gout.
- Applied Immune Technologies — Applied Immune Technologies Ltd. engages in development of therapeutic molecules for cancer, viral, and autoimmune diseases. The company develops T-Cell Receptor-Like (TCRL) antibodies that are targeted to intracellular-derived peptides for various therapeutic and diagnostic applications. Its TCRL antibodies also have diagnostic applications inpathology; and vaccine design, validation, and monitoring, as well as in the analysis of antigen presentation in disease. The company was formerly known as BioMimic Pharma. The company was founded in 2006 and is based in Haifa, Israel.
The Israel Innovation Agency, the Innovation Authority, was established in 1965 as the Office of the Chief Scientist of the Ministry of Industry and Trade and was designed as a body that supports R & D conducted in the framework of government research institutes. Industrial development in order to increase industrial exports of high-techproducts. The Chief Scientist focused on reducing the risk by participating in financing the project, which the private companies chose and led.
Show more...Investment focus
- Industry: Health Care, Artificial Intelligence, Biotechnology
- Stage:Grant, Seed, Pre-Seed
- Geography: Israel, United States, Mali
Investor stats
- Total investments: 217
- Round size: Seed $400k–$6M; Grant $130k–$3.5M; Pre-Seed $100k–$2.1M
- Lead/follow: 47% lead, 53% follow
- Last fund: Likely still investing — raised $10M in 2023
Portfolio highlights
- Brevel — Brevel developed a disruptive cultivation technology for sustainable, low cost and high quality production of microalgae for various yet untapped markets. The technology is based on high-tech indoor, sterile and fully automated systems which are illuminated from within at high intensity. The technology enables the surprising results of more than90% cost reduction and up to 200 higher yields compared to current alternatives. Brevel is using the advantageous production capabilities to enter multiple markets where microalgae derived products are needed.
- PulseNmore — Pulsenmore (TASE:PULS) is a world leader in self-scan ultrasound devices for remote clinical diagnosis and screening.
- GeoRank Studio — GeoRank Studio is a specialist SEO, Generative Engine Optimisation (GEO), and Reputation Management agency helping businesses across the UK, EU, and US gain visibility in both traditional and AI-powered search.As AI search engines including ChatGPT, Perplexity, and Google AI Overviews now answer a growing share of commercial queries without aclick, GeoRank Studio helps businesses adapt. We implement the technical and content changes needed to get brands cited in AI-generated answers — a discipline known as Generative Engine Optimisation or GEO.Our core services include technical SEO audits and full implementation, GEO optimisation including FAQPage schema markup, entity optimisation, and AI crawler configuration, reputation management including review removal from Google and Trustpilot, negative SERP suppression, and monthly AI citation tracking reports.GeoRank Studio was founded in 2022 and operates fully remotely, serving clients in professional services, SaaS, hospitality, luxury retail, and e-commerce. All packages include a 14-day money-back guarantee.Official Website: georankstudio.com
Trendlines Group invents, discovers, invests in, and incubates innovation-based medical and agrifood technologies. Trendlines invests principally through medical and agrifood incubators in Israel and in Singapore, its in-house innovation center, Trendlines Labs, and its Funds - the Trendlines Agrifood Fund and the Bayer Trendlines Ag InnovationFund.The company was founded in 1993 and is headquartered in Misgav, Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Seed, Venture - Series Unknown
- Geography: Israel, Singapore, United Kingdom
Investor stats
- Total investments: 70
- Round size: Seed $650k–$4.1M; Venture - Series Unknown $1M–$62M
- Lead/follow: 21% lead, 79% follow
- Last fund: May invest from a new fund soon — raised $40M in 2019
Portfolio highlights
- IBI-Ag — We develop a wide array of selective bio-insecticides to help farmers grow more at lower cost with no harm to farm workers, consumers and the environment.
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Arcuro Medical — Arcuro develops a new repair system for meniscus tears of the knee. Arcuro’s proprietary SuperBall repair system consists of a knotless, all-suture anchor and innovative delivery system. The company was founded in 2013.
HIMAngel is a venture capital and private equity firm that supports early-stage startups to grow. It fills the funds' gap as there is an increasing focus on growth-stage VC funds, but little attention and even less money made available for early-stage investments. HIMAngel was founded in 2017 and headquartered in Cairo, Al Qahirah.
Show more...Investment focus
- Industry: Food and Beverage, E-Commerce, Agriculture
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Egypt, Saudi Arabia, United States
Investor stats
- Total investments: 28
- Round size: Seed $100k–$860k
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Rology — AI-assisted On-demand Teleradiology Platform
- GBarena — GBarena is an online esports platform that serves the ecosystem stakeholders by the combination of a strong network of different esports communities, and a highly analytical tool to provide authentic value for all stakeholders (Publishers, Gamers, Tournament Organizers, Sponsors, Teams, and Media Partners).
- Shezlong — Talk to your therapist online privately anytime anywhere!
F6 Ventures is a leading seed stage venture capital firm operating across emerging markets. We back exceptional founders from idea-stage all the way to Series A, combining early capital with strategic support and a commitment to long-term partnership. With deep ties across the Middle East, Africa, and beyond, we empower innovative startups to scalewith purpose and impact. We manage over $90M in AUM across more than 300 investments in seven countries. By investing early in Pre-Seed to Pre-Series A rounds, we help founders cover initial costs, develop their product, and take it to market. This early capital acts as a launchpad, enabling startups to hit key milestones like securing first customers, attracting follow-on funding, and making significant strides forward.
Show more...Investment focus
- Industry: Software, E-Commerce, Information Technology
- Stage:Pre-Seed, Seed, Non-Equity Assistance
- Geography: Egypt, United Arab Emirates, Saudi Arabia
Investor stats
- Total investments: 365
- Round size: Seed $15k–$1.1M; Pre-Seed $49k–$600k
- Lead/follow: 44% lead, 56% follow
- Last fund: Likely still investing — raised $95M in 2023
Portfolio highlights
- Tagaddod — Tagaddod is a renewable Energy and Waste Management Egyptian company, started in February 2013 and operating in Cairo –Egypt. Currently focusing on clean fuels, Tagaddod is working on Biodiesel production from Vegetable Oils. Biodiesel is a fuel alternative that is produced from waste vegetable oils and used in conventional diesel engines, whichcan directly substitute for or extend supplies of traditional petroleum diesel.
- Makan Home — SHEN168 adalah situs toto togel online yang terpercaya, menawarkan pengalaman bermain yang aman dan menyenangkan bagi para penggemar togel online.
- MyAlice — The modern customer service and social selling platform. Support anytime and sell anywhere with all your messages, orders, and agents in one place.
Diffusion Capital Partners (DCP) is Turkey's leading Venture Capital fund manager with a focus on deep-tech opportunities.
Show more...Investment focus
- Industry: Software, Information Technology, SaaS
- Stage:Seed, Pre-Seed
- Geography: Turkey, United States, United Kingdom
Investor stats
- Total investments: 65
- Round size: Seed $350k–$3M; Pre-Seed $59k–$1.4M
- Lead/follow: 54% lead, 46% follow
- Last fund: May invest from a new fund soon — raised $35M in 2020
Portfolio highlights
- BigOmics — Get robust and reproducible results in a few clicks with Omics Playground: your user-friendly Omics Data Analysis Software.
- Etched — Transformers etched into silicon. By burning the transformer architecture into our chips, we're creating the world's most powerful servers for transformer inference.
- GoWit Technology — Unlock your retail media potential with GoWit's omnichannel Retail Media Advertising platform. Expand your audience reach, optimize bidding, and leverage first-party data for maximum conversions and privacy protection.
Hadasit Bio-Holdings Ltd. ("HBL") was founded and floated on the Tel Aviv Stock Exchange (TASE : HDST ) and recently on the OTC (OTCBB : HADSY ) in order to allow public participation in the highly promising field of biotechnology.It serves as a precedent in biotech financing - for the first time, public investment is allowed toparticipate in a holding entity including companies based on IP generated by Israel’s foremost medical research center – Hadassah University Hospital ("HU").In addition to the public holdings (54%) – including major Israeli institutional investors, HBL is held by Hadasit (www.hadasit.co.il) (36%) and Consensus Business Group (http://www.consensusbusiness.com) (10%). The traded stock, as a unique investment vehicle, provides investment exposure to a select cluster of 6 biotech companies - all based on inventions developed and owned by HU.HBL is a publicly traded subsidiary of Hadasit Ltd. – the technology transfer company of the Hadassah University Hospital in Jerusalem, Israel. Hadasit was established for the purpose of promoting and commercializing the intellectual property (IP) and R&D capabilities generated by Hadassah, aimed at finding solutions to problems faced by modern medicine.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: Israel
Investor stats
- Total investments: 11
- Round size: Venture - Series Unknown $10M–$47M
- Lead/follow: 9% lead, 91% follow
Portfolio highlights
- ProtAb — ProtAb develops therapeutic agents that modulate cytokine regulation, tipping the balance toward anti-inflammatory signaling pathways in the treatment of autoimmune and inflammatory diseases. Its first product, Prozumab, is a monoclonal antibody with a novel mechanism of action. It is currently in late-stage preclinical development for thetreatment of inflammatory bowel disease or IBD, ulcerative colitis or UC, and rheumatoid arthritis or RA. It operates as a subsidiary of Hadasit Bio-Holdings. HBL is a publicly traded subsidiary of Hadasit, the technology transfer company of the Hadassah University Hospital in Jerusalem in Israel.
- KAHR medical — KAHR Medical ("KAHR") is pioneering the development of "third generation biological drugs," a unique class of proprietary fusion-protein molecules with clear and far-reaching advantages. KAHR's technology represents a paradigm shift in protein-based pharmaceuticals that will significantly expand available treatment optionsfor cancer and autoimmune disorders.
- Enlivex Therapeutics — Enlivex is a clinical-stage macrophage reprogramming immunotherapy company that targets diseased macrophages in patients with sepsis. The company develops an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn'sDisease, and other autoimmune and inflammatory disorders.The company's revolutionary approach is to induce immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells.
Cybele Group is a full service consulting and financial services firm, which provides investment banking, brokerage and asset management services to both corporations and a wide array of clients, ranging from individuals and small businesses to the world's largest corporations and governments.
Show more...Investment focus
- Industry: Health Care, Real Estate, Biotechnology
- Stage:Post-IPO Equity, Venture - Series Unknown, Series D
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 73
- Round size: Post-IPO Equity $787k–$77M; Venture - Series Unknown $524k–$98M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Silverbyte — Optima is an international, top notch Hotel Management Software solution for medium to high end hotels and groups with over 1000 installations in 34 countries.
- Cannabotech — Cannabotech develop, and assimilate the medicinal properties of Cannabinoids & Mushrooms, integrated with cutting-edge technologies at world-class standards.
- Smart Agro — Smart Agro specializes in investing and improving companies in the agro-tech fields.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Venture - Series Unknown, Series A
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 55
- Round size: Series A $6M–$24M; Series B $7.7M–$28M; Venture - Series Unknown $3.6M–$20M
- Lead/follow: 25% lead, 75% follow
- Last fund: Likely still investing — raised $70M in 2021
Portfolio highlights
- Descope — Add passwordless authentication, user management, and authorization to your app with a few lines of code. Choose from our drag-and-drop workflows, SDKs, or APIs.
- FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
- Cala Health — Cala Health is a bioelectronic medicine company transforming the standard of care for chronic disease. The company's wearable neuromodulation therapies merge innovations in neuroscience and technology to deliver individualized peripheral nerve stimulation. The first indication for Cala Health's wearable therapy is an essential tremor, adisease experienced by more than seven million people and characterized by severe hand tremors. New therapies are under development in neurology, cardiology, and psychiatry. The company is headquartered in the San Francisco Bay Area and backed by leading investors in both healthcare and technology.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Ales Venture Capital Investment Trust Inc. 100% Escort Technology Investment Co., Ltd. was established in late 2012 as a subsidiary of an investment company subject to the Capital Markets Board legislation.Their target audience was primarily started to produce products or services are targeted at companies with existing customers and growth.However, the product or service to switch to the sales and marketing process, although in need of ready finance companies also take interest in Their initiative.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Turkey, United States, Estonia
Investor stats
- Total investments: 134
- Round size: Seed $30k–$600k; Pre-Seed $26k–$150k; Convertible Note $30k–$4.6M
- Lead/follow: 20% lead, 80% follow
- Last fund: May invest from a new fund soon — raised $5M in 2012
Portfolio highlights
- GlaucoT — GlaucoT develops contact-free intraocular pressure monitoring and neuroprotective treatment technology for glaucoma disease.
- Kozmonot — Kozmonot is a mobile competition application with real money prizes focused on knowledge, research and intelligence.
- ConverJinn — Paste a product link and the Jinn writes a conversion-driven description with SEO-smart HTML, ready to drop into your store.
Access curated startup investment opportunities and diversified venture capital exposure designed for accredited investors.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 2705
- Round size: Seed $850k–$9.9M; Series A $3.5M–$32M; Series B $8M–$75M
- Lead/follow: 4% lead, 96% follow
- Last fund: Likely actively investing — fresh fund, raised $90k in 2026
Portfolio highlights
- Particle — Afternic is a one-stop site to buy, sell and park domains. See for your self why Afternic is the world's premiere domain marketplace and exchange reseller.
- Akiba Digital — Akiba Digital is a data and technology company that provides financial intelligence solutions. Our vision is to to unlock financial opportunities for consumers, businesses and society using alternative data.
- Enact — Enact is a leading solar energy and solar software company serving homeowners, businesses, and installers. Get a free quote or request a demo today!
Qatar Development Bank they improve the economic development cycle by providing entrepreneurs and SMEs with a wide range of financial and advisory products under one roof.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Financial Services
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: Qatar, United States, United Arab Emirates
Investor stats
- Total investments: 55
- Round size: Seed $275k–$2M; Pre-Seed $52k–$1.2M; Venture - Series Unknown $82k–$3M
- Lead/follow: 20% lead, 80% follow
Portfolio highlights
- Dawraty — Dawraty is an AI-driven eLearning platform redefining how students in medicine, engineering, and other professional fields learn and succeed. Dawraty combines expert-led video lectures with personalized study guides, adaptive quizzes, and 24/7 AI tutoring to create an individualized learning experience. Headquartered in Abu Dhabi Global Marketwith regional hubs in Kuwait and Bahrain, Dawraty partners with top instructors and universities to deliver curriculum-aligned, affordable, and engaging education. The platform currently serves thousands of students across the Gulf and is expanding into Saudi Arabia, the UAE, and Jordan. Dawraty’s mission is to make high-quality, personalized education accessible to every learner. Its AI-driven technology personalizes content to each student’s learning style, enabling them to study smarter and achieve better outcomes.
- Tanami Capital — Tanami Capital is an investment management firm that specializes in asset management, advisory, and financial services.
- Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Endure Capital is an early stage investment fund headed by entrepreneurs looking for startup teams. They look for founders who are relentlessly resourceful and imaginative, solving genuine problems that matter to a lot of people and building high growth companies that endure.
Show more...Investment focus
- Industry: Software, Health Care, E-Commerce
- Stage:Seed, Series A, Series B
- Geography: Egypt, United States, United Kingdom
Investor stats
- Total investments: 78
- Round size: Seed $120k–$5.5M; Series A $1M–$33M; Series B $6M–$42M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — raised $50M in 2022
Portfolio highlights
- Pyka — We believe that electrification and automation will make aviation safer, more affordable, and more accessible than has ever been possible in human history.
- ShopLook — Online personal styling destination. Discover outfit ideas or virtually create your own using our outfit maker.
- TwentyToo — TwentyToo is a user-centric approach and the application of AI and ML.
Docor International B.V. is a fully-owned subsidiary of Crecor B.V. Both Docor and Crecor were formed as wholly-owned subsidiaries of the Van Leer Group Foundation to promote and participate in commercial activities in Israel.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series C, Venture - Series Unknown
- Geography: Israel, United States
Investor stats
- Total investments: 18
- Round size: Series C $13M–$22M; Venture - Series Unknown $8M–$15M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Raziel Health — Raziel Health’s mission is to bring world-class, disruptively less expensive healthcare to everyone, in the comfort of their home. Its unique, integrated system combines easy-to-use technologies that support positive patient experience, enable timely clinical intervention, and meet individual patient goals while using data analytics to supportwellness and disease management.
- SP Nano — SP Nano is a nanotechnology company commercializing the use of nano-particles in the rapidly growing $106 billion composites market. The most widely-used type of composite consists of layers of fabric (carbon-fiber, glass-fiber, aramid) held together by a resin matrix. The matrix is the materials' weakest link - much weaker than the layersof fibers it binds. When composite structures and components commonly used in the aerospace, defense, automotive, marine and sporting goods industries fail, it's often because of this large discrepancy in strength between the fibers and the resin.
- Raziel Therapeutics — Raziel's drug aims for fat melting by harnessing the body’s own natural healing power and delivering proven biological activity.
S2G Ventures is is a multi-stage venture fund investing in food and agriculture. We're harnessing the power of food innovation to create better outcomes for people and the planet.
Show more...Investment focus
- Industry: Food and Beverage, Agriculture, Biotechnology
- Stage:Series A, Series B, Venture - Series Unknown
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 229
- Round size: Series A $4M–$55M; Series B $3.9M–$100M; Venture - Series Unknown $4.3M–$100M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely actively investing — fresh fund, raised $1B in 2026
Portfolio highlights
- Kanin Energy — Our solution transforms industrial waste heat into clean baseload electricity, boosting energy efficiency, cutting costs, improving reliability, and lowering
- Corvus Robotics — Autonomous inventory intelligence for the physical economy. Corvus Robotics drones and AI forklift sensors count inventory in Fortune 500 warehouses.
- Energy Vault — Energy Vault creates gravity and kinetic energy-based, long-duration energy storage solutions that are transforming the world's approach to energy storage.
aMoon is a leading healthtech & life sciences venture fund founded by Marius Nacht and Dr. Yair Schindel. Their team is passionate about building successful businesses and helping biopharma, digital health and medical technology companies realize their potential. They partner with management teams who use technology and cutting-edge science toaccelerate cures for the world’s most life-threatening conditions and those providing solutions for global healthcare’s biggest cost drivers.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, France
Investor stats
- Total investments: 80
- Round size: Series A $5.7M–$82M; Series B $22M–$93M; Series C $30M–$82M
- Lead/follow: 49% lead, 51% follow
- Last fund: Likely still investing — raised $340M in 2022
Portfolio highlights
- Lin Health — Online chronic pain recovery program designed to get you back to the life you want to live. One-on-one coaching. Real pain reduction results.
- Connie Health — At Connie Health, our Medicare advisors help older Americans find the right Medicare plan - all at no cost to you.
- Hopscotch Primary Care — We provide primary care services to seniors on Medicare, offering more time with your doctor, and a full care team to support all of your healthcare needs.
Agriline is the investment vehicle owned by a trust of which Trendlines' controlling shareholder Vincent Tchenguiz.
Show more...Investment focus
- Industry: Health Care, Medical, Biotechnology
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: Israel
Investor stats
- Total investments: 15
- Round size: Seed $1.3M–$7.5M; Series A $5M–$17M; Venture - Series Unknown $2.2M–$16M
- Lead/follow: 13% lead, 87% follow
Portfolio highlights
- Phytolon — Phytolon revolutionizes the way food colors are produce, by Leveraging a novel and sustainable technology for production of healthy food colors in high quality at low costs. Phytolon's mission is to exploit scientific advancement promote human health and environmental sustainability
- Vessi Medical — Vessi Medical is developing an innovative, IP protected cryo spray for hollow & humid organs, a new approach in the treatment of Non Muscle Invasive Bladder Cancer (NMIBC).
- SetBone Medical — SetBone Medical develops a new bone cement for the treatment of VCF and primarily caused by osteoporosis.
Elron Ventures is an early-stage investor committed to turning promising ideas into global industry leaders, with a proven track record of investments and successful M&As worldwide. Elron invests in cyber security and B2B software. Since its establishment in 1962, Elron stands on the forefront of Israeli innovation both as a founder and earlyinvestor in companies across various industries such as Elbit, Medingo, Given Imaging, Cloudyn, Cyber Secdo, and Alcide.
Show more...Investment focus
- Industry: Information Technology, Software, Cyber Security
- Stage:Series A, Seed
- Geography: Israel, United States, China
Investor stats
- Total investments: 66
- Round size: Seed $1.5M–$15M; Series A $1M–$17M
- Lead/follow: 42% lead, 58% follow
Portfolio highlights
- Brainsgate — BrainsGate's platform technology involves electrical stimulation of the Spheno-Palatine Ganglion (SPG), a nervous center known to increase cerebral blood flow. BrainsGate is exploring several applications for its technology, and is currently focusing on treatment of acute ischemic stroke. Building on its technology, the Company has developedthe ISS, based on a miniature electrode implanted at the roof of the mouth in a bed side, minimally invasive, local anesthesia procedure comparable to dental treatment. In 2008, the company completed ImPACT-1, a pilot clinical trial for acute ischemic stroke with promising results. In 2011 the Company completed a 300 patients RCT pivotal trial that further substantiated the safety and efficacy of its treatment for acute ischemic stroke patients. BrainsGate is currently running the ImpACT-24b, a multi-national, randomized, double-blind, sham-controlled pivotal study to assess the safety and efficacy of its treatment for stroke patients in a 24-hour window.
- Raven.io — Secure apps with our Runtime Protection Platform. De-prioritize 99% of vulnerabilities with runtime reachability and prevent exploits, zero-days and supply chain attacks with intelligent, library-level policies.
- CyberRidge — CyberRidge is a deep-tech cybersecurity firm that develops photonic encryption to protect data privacy.
Btomorrow Ventures (BTV) is the corporate venturing unit of BAT. BAT is building A Better Tomorrow by reducing the health impact of its business by transforming into a truly consumer-centric multi-category CPG company. We are dedicated to partnering with ambitious and passionate entrepreneurs to realise their vision by providing a platform toenhance innovation and accelerate growth.
Show more...Investment focus
- Industry: Health Care, Wellness, Food and Beverage
- Stage:Series A, Seed, Series B
- Geography: United States, United Kingdom, India
Investor stats
- Total investments: 44
- Lead/follow: no public data
Portfolio highlights
- Tru — Obsessively formulated by fusing flavor with function, each of our tasty innovations perform when you need it most. From the time you wake up until the second your head hits the pillow, we elevate every moment one sip at a time.
- Awake Chocolate — AWAKE Chocolate combines delicious milk chocolate.
- PHILTER Labs — Philter Labs presents an innovative smoke filter for E-Cig, Vape Pen, & CBD Pen. Filters smoke from entering shared space while you still enjoy the experience.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!We partner early with global-minded entrepreneurs seeking to disrupt large markets
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, Canada
Investor stats
- Total investments: 189
- Round size: Series A $3.5M–$28M; Series B $5M–$35M; Series C $5.6M–$100M
- Lead/follow: 17% lead, 83% follow
- Last fund: Likely still investing — raised $170M in 2022
Portfolio highlights
- Rylo — Nagish captions your phone calls and empowers you to talk using text or voice. It's fast, private, and free.
- Aternity — Unlocking the full potential of your digital experiences has never been more accessible. Illuminate, accelerate and fully leverage the full breadth of possibilities with Riverbed.
- Adaptive6 — Cloud Cost Governance: Govern Cost Across Your Cloud and Code. Prevent and Remediate Waste. At Scale.
We are an early stage venture capital firm dedicated to partnering with inspiring entrepreneurs to build breakthrough companies
Show more...Investment focus
- Industry: Software, Health Care, Machine Learning
- Stage:Seed, Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 41
- Round size: Seed $1M–$2.5M; Series A $2.1M–$14M; Series B $15M–$30M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $9.6M in 2021
Portfolio highlights
- ViewNetic — ViewNetic is an AgTech startup developing unique imaging and machine learning technologies for early, pre-propagation detection of pests and diseases in high-value crops.
- Infiniplex — Infiniplex is an Israel-based startup whose mission is to utilize routine blood testing to screen for genetic tumor biomarkers and to offer preemptive, preventive, and follow-up cancer screenings at a more accessible and affordable cost. Our goal is to identify common and rare cancer types through a standard, inexpensive blood test that could becarried out as part of routine checkups, leveraging existing laboratory equipment and know-how. We aim to include tumor genomic testing as part of people's standard blood test checkups. The company was founded in 2021 and is based in Yokne'am Illit, Israel.
- Intuition Robotics — The AI care companion robot for older adults
Robin Hood Ventures investments for startups range from $250,000 to $1 million. We syndicate with venture capitalists, institutions, and other network angels.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A, Convertible Note
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 165
- Round size: Seed $210k–$4.3M; Series A $180k–$11M; Convertible Note $26k–$560k
- Lead/follow: 8% lead, 92% follow
Portfolio highlights
- Aseon Labs — Robotic pitstops for self driving cars. A depot in a box for charging, cleaning & inspecting AVs directly in operating zones. Backed by @ycombinator
- Cooler Heads — Cooler Heads develops cold caps designed for chemotherapy patients.
- Surface Design Solutions — Surface Design Solutions uses physics-informed AI to help manufacturers reduce scrap, improve yield, and diagnose costly surface performance issues.
TAL Ventures (TAL) is an Israel based Venture Capital group with deep ties to the Israel high-tech ecosystem.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A, Pre-Seed
- Geography: Israel, United States, Cyprus
Investor stats
- Total investments: 59
- Round size: Seed $3M–$12M; Pre-Seed $2.1M–$4M; Series A $5M–$25M
- Lead/follow: 24% lead, 76% follow
- Last fund: Likely still investing — raised $4.7M in 2022
Portfolio highlights
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Yuki — Reduce warehouse waste, prevent budget spikes, and keep queries fast across Snowflake and BigQuery. Yuki keeps AI workloads under control with budgets and priorities built in, optimizing in real time with zero engineer effort.
- Majestic Labs ai — Majestic Labs ai builds power-efficient AI servers for the largest and most advanced AI workloads.
Clal Biotechnology Industries is a leading Israeli life sciences investment company traded on the Tel Aviv Stock Exchange (TASE: CBI).
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 18
- Round size: Series A $4M–$55M; Series B $15M–$40M
- Lead/follow: 11% lead, 89% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- TytoCare — TytoCare offers the Home Smart Clinic - for accessible, high-quality primary care from home, with no compromises.
- Sight Diagnostics — Combining AI and breakthrough hardware to bring lab-quality CBC results to the doctor's office.
- Cadent Therapeutics — Cadent Therapeutics is a precision neuroscience company developing novel medicines that tune and modulate brain rhythms to restore cognitive and motor function in patients with serious neurological disease. The company leverages its precision neuroscience approach combining target specificity, patient selection, drug design and optimization, andnovel quantitative endpoints to create first-in-class molecules to treat movement and cognitive disorders.It was founded in 2010 and headquartered in Cambridge, Massachusetts.
Mindset Ventures is an early-stage VC firm that supports entrepreneurs in their growth and international expansion. The firm targets B2B startups technology applied to Agriculture, Financial Services, Healthcare, Cybersecurity, Education, and Enterprise Software industry. It was founded in 2016 and headquartered in Sao Paulo, Brazil.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 112
- Round size: Seed $1.9M–$14M; Series A $5.5M–$30M; Series B $6.8M–$35M
- Lead/follow: 14% lead, 86% follow
- Last fund: May invest from a new fund soon — raised $50M in 2019
Portfolio highlights
- Alta — Alta leverages data and AI to drive business growth 24/7.
- Belo — Crypto for everyone, everyday
- Mogul — Your path to financial success in the music business.
TechWald Holding S.P.A. - TWH - Operational Holding Company supporting high growth potential early stage companies committed to develop Healthcare Innovation.We have a key strategy focus on MedTech industry and Medical Technologies - medical devices, equipment, digital devices and services -which can provide benefit and value for Patients, Doctors and Healthcare Systems,and reward Shareholders with a sound and ethical profit
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Series C
- Geography: Israel, United States, Switzerland
Investor stats
- Total investments: 10
- Round size: Series A $3.6M–$7.1M; Series B $8.5M–$48M; Series C $9.3M–$60M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
- RapidPulse — Explore RapidPulse for innovative stroke treatments and technologies. Book appointments or learn about our team and clinical trials.
- Lymphatica Medtech — Lymphatica Medtech is a medical device development company developing a minimally invasive solution for chronic lymphedema.Lymphedema is the chronic swelling that generally occurs in the arms or the legs.Lymphedema is most commonly caused by the removal of or the damage to the lymph nodes as a part of cancer treatment. It results from ablockage in the lymphatic system, which is part of the immune system. The blockage prevents the lymphatic system from draining excess fluids, and the fluid buildup leads to swelling, infections, and pain.Unfortunately, there is no cure for lymphedema. It can be managed with early diagnosis and diligent care of the affected limb, through daily compression, bandages, and manual drainage sessions. From the moment of the diagnosis, the life of lymphedema patients changes forever.Cancer and cancer-related interventions (i.e. surgery, radiotherapy) are frequent causes of lymphedema occurring both in the upper and lower limbs. Breast cancer survivors are at high risk for developing lymphedema, as well as patients treated for melanoma, pelvic and head and neck cancer or other cancer treatments that require lymph node dissection. Physical trauma can also result in lymphedema, a major cause of lymphatic disease among wounded veterans.Lymphedema is associated with significantly impaired quality of life, skin changes, increased risk of infection and in rare cases lymphedema itself may undergo malignant transformation.Lymphatica offers a permanent solution that will allow patients to regain their normal lifestyle.
Accelmed is a venture capital firm that funds private and public medical device companies with significant market potential and proven clinical data.Concentrating on medical device companies that have already reached the revenue stage enables the firm to assist companies in benefiting from its managerial capabilities and financial resources.Together with the management teams of their portfolio companies, the Accelmed can steer the way from the clinical-stage to a profitable business with a clear commercial plan, thereby accelerating the path to a successful exit.In 2009, Mori Arkin and Uri Geiger, the co-founders of Accelmed, established the firm in Herzliya, Tel Aviv.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series D, Series A
- Geography: United States, Israel
Investor stats
- Total investments: 42
- Round size: Series A $695k–$24M; Series D $13M–$96M
- Lead/follow: 48% lead, 52% follow
- Last fund: May invest from a new fund soon — raised $401M in 2020
Portfolio highlights
- Corvia Medical — Corvia Medical is a medical device company, focuses on developing structural heart devices for the treatment of heart failure. The company develops InterAtrial Shunt Device (IASD), a transcatheter device designed to treat diastolic heart failure (DHF), also known as heart failure with preserved ejection fraction (HFpEF). It was founded in 2009and headquartered in Andover, Massachusetts.
- UltraClear — UltraClear is a skincare clinic that provides facial rejuvenation solutions for the treatment of all skin types.
- GT Medical Technologies — GT Medical Technologies, Inc. (GT), an Arizona-based medical device company, is focused on improving the lives of patients with brain tumors. GT has developed an innovative approach to treatment by combining a conformable collagen matrix with brachytherapy (radiation) seeds. The company's first product, GammaTile™ is protected by 10 US and 2Canadian issued patents, and 1 EPO patent. The product has the promise to revolutionize treatment for 176,000 patients/year in the US alone. To date, we have treated 120 patients with recurrent brain tumors in a clinical trial at Barrow Neurological Institute (BNI) and observed significant clinical improvement.
Musharbash
Show more...Investment focus
- Industry: Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: Qatar
Investor stats
- Total investments: 3
- Round size: Pre-Seed $1.2M–$1.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- MetaDoc — Once you are registered in our system, you get 24/7 access to the best western-trained doctors. If you are too sick to leave home or just need a piece of advice, a doctor's visit or medication delivery, you can count on us.
XTX Ventures is the venture capital arm of XTX Markets. XTX Markets is a leading, innovation-driven algorithmic trading firm.XTX Ventures focuses on early stage startups (Seed to Series A) applying machine learning and leverages XTX Markets’ deep expertise in ML and financial technology to help grow and enhance those businesses. We are geographyand industry agnostic.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Machine Learning
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 97
- Round size: Seed $2M–$7.6M; Series A $6M–$60M; Series B $10M–$200M
- Lead/follow: 21% lead, 79% follow
- Last fund: Likely still investing — raised $9.6M in 2024
Portfolio highlights
- Jenesys AI — Meet Jack, your AI-powered bookkeeping agent, automates line-item extraction, GL coding, and bank reconciliation with real-time insights.
- Qureight — Pioneering data curation to solve complex diseases
- Maven Robotics — Maven Robotics is building the world's leading general purpose AI robots.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Speed is a tech accelerator based out of the Beirut Digital District that empowers software startups to succeed and scale globally through a 3-month mentorship-driven program, $30,000 in funding, and a lifelong network of mentors and partners.The accelerator offers software startups $30,000 in financial support, an intensive 3-monthmentorship-driven program that includes in-house mentorship, mentorship from experts, workshops, access to a network of investors, and a free working space at BDD, in exchange for 5% equity in common shares. Startups also receive lifelong support from a network of 100+ local and international mentors, the opportunity to be sponsored by Speed for a 2-week immersion program in Silicon Valley in partnership with LebNet, technology perks worth $1M+ through the accelerator’s partnership with the Global Accelerator Network (GAN), and a fast-track referral to the 47 Techstars programs around the world.
Show more...Investment focus
- Industry: E-Commerce, Apps, Internet
- Stage:Seed, Pre-Seed
- Geography: Lebanon, United Arab Emirates, United States
Investor stats
- Total investments: 34
- Round size: Seed $30k–$500k; Pre-Seed $30k–$300k
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- PawPots — PawPots is a pet service that offers real and healthy food made for dogs. It is designed with the perfect balance of protein, carbohydrates, and healthy oils which help build strong immunity. The company provides a healthy diet alternative for pets and an online platform for pet parents and vets.
- Sidelick — Pet parenting made easy! Browse through tens of reviewed pet sitters and dog walkers around you to find the best fit for your pets.
- Scriptofilm Corp. — Scriptofilm is an interactive platform that links scriptwriters and filmmakers to producers, investors, and buyers.
Alon MedTech Ventures is active in the initiation and growth of young high-tech companies in the medical device arena. They seek to make a difference: Alon MedTech is engaged with novel technologies that improve human well-being and quality of life.Owned by leading Israeli Entrepreneur Dr Shimon Eckhouse, Alon MedTech is backed by a powerfullegacy. Dr Eckhouse has founded and invested in numerous medical technology firms, two of which are leading international companies, (ESC Medical [Lumenis] and Syneron Medical), both traded on NASDAQ.Their experience, professionalism, wide network and solid financial resources enable them to provide their companies with distinctive sponsorship. This includes such key factors as technological and managerial guidance, strategic counseling and fundraising.The objective of this private incubator is to accompany young ventures through all stages, from lab to marketplace – and beyond. From conceptualization of product through to company success, their assistance can extend for years after a company is up and running.Alon MedTech couples the highest levels of technological knowhow with long years of business acumen. The result: a rich and fertile environment for growing successful companies.
Show more...Investment focus
- Industry: Health Care, Medical, Medical Device
- Stage:Seed, Venture - Series Unknown, Series B
- Geography: Israel, United States
Investor stats
- Total investments: 6
- Round size: Seed $900k–$2.2M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- Anchora Medical — Anchora Medical focuses in simplifying of suturing in endoscopic and open surgery applications. The company develops a unique, single-use automatic suturing device for minimal invasive surgery.
- Serenno Medical — Serenno Medical is a medical device company creating a urine-output measuring device for the ICU. The company is the developer of a bedside urine output measuring device for hospitalized patients, offering accurate and automatic measurements with low costs, less workload, and improved patient safety.Serenno Medical was founded in 2017 and isheadquartered in Yokne'am Illit, Israel.
- Levron Medical — Levron Medical develops a novel autonomic integrated diagnostic and therapeutic device used to treat heart failure patients.
Investment focus
- Industry: Manufacturing, Biotechnology, Software
- Stage:Grant, Venture - Series Unknown, Seed
- Geography: Spain, Italy, United Kingdom
Investor stats
- Total investments: 2435
- Round size: Seed $52k–$1.1M; Grant $54k–$2.1M; Venture - Series Unknown $573k–$2.6M
- Lead/follow: 27% lead, 73% follow
Portfolio highlights
- AGADE — Esoscheletri Agade | Il primo esoscheletro intelligente per lavoratori progettato per ridurre il rischio di disturbi muscolari delle spalle nella movimentazione manuale dei carichi.
- BroadBit Batteries — BroadBit is a technology company developing revolutionary new batteries using novel sodium-based chemistries to power the future green economy.
- Aenitis Technologies — We develop innovative devices for cells therapy processing using Acoustic Radiation Forces.
Insight Partners is a global software investor partnering with high-growth technology, software, and Internet startup and ScaleUp companies.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, Germany
Investor stats
- Total investments: 1445
- Round size: Series A $12M–$70M; Series B $17M–$110M; Series C $25M–$150M
- Lead/follow: 68% lead, 32% follow
- Last fund: Likely actively investing — fresh fund, raised $13B in 2025
Portfolio highlights
- Vela — Vela is a leading independent provider of data and execution technology for global multi-asset electronic trading. Our software enables clients to rapidly access global liquidity, markets, and data sources for superior execution. We help firms successfully differentiate and innovate in an ever-changing, increasingly regulated, and fiercelycompetitive landscape, while also reducing total cost of ownership. Vela’s market data, execution and automated trading software deliver a unique, ultra-low latency technology stack to simplify and streamline electronic trading. We leverage the latest innovations in technology to deliver cutting-edge performance, features and reliability. Our modular stack provides access to a comprehensive set of trading data and risk APIs and can be delivered “as-a-Service” from multiple co-location data centers globally. With access to more than 250 venues, Vela provides global coverage across all major asset classes. Clients are supported by an award-winning team of technical and business experts available 24x7 from our multiple offices in the U.S., Europe, and Asia. Vela’s clients include traders, market makers, brokers, banks, investment firms, exchanges, and other market participants.
- Pluralsight — Pluralsight is the technology workforce development company that helps teams know more and work better together with stronger skills, improved processes and informed leaders.
- Profluent Bio — Profluent Bio is an AI-first protein design company that designs novel, optimal proteins that bypass existing barriers in industry.
Acibadem University is the Largest Private Healthcare University in Turkey
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed
- Geography: Turkey
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Hevi AI — Hevi AI provide innovative artificial intelligence-based solutions for medical imaging for a diverse spectrum of diseases varying from detection of critical pathologies to radiomics applications for oncology.
Neo Ventures is a venture capital investment platform focused on deep tech, funds and high-growth startup portfolio.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 20
- Round size: Seed $500k–$2.9M; Series A $2.3M–$24M
- Lead/follow: 30% lead, 70% follow
Portfolio highlights
- Bulbi — Bulbi is a child development platform designed to help parents discover online and face-to-face educational activities for their children.
- Convex — All gas, no breakages. Convex is the reactive backend platform that keeps up with you and your agents.
- Extend Robotics — Extend Human Capabilities Beyond Physical Presence
Ziegler is a privately held investment bank, capital markets and proprietary investments firm.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Mobile
- Stage:Series C, Series E, Series F
- Geography: United States, Israel
Investor stats
- Total investments: 6
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $26M in 2014
Portfolio highlights
- Aposense — Aposense (formerly NST) is a clinical-stage molecular imaging and drug development company, with a pipeline of products based on its patented platform technology for targeting apoptosis (programmed cell death) in vivo. The company translating the science of Apoptosis (programmed cell death) into personalized patient care in multiple diseasecategories, including oncology, cardiology, and neurology. Targeting of this important biological process in-vivo opens opportunities for real-time clinical imaging of disease activity and targeted therapy.Aposense specializing in the development of novel drugs and utilizing membrane electrical forces for trans-membrane of macromolecule drugs, mainly siRNA. It also developed rationally-designed molecular nano-motors (MNMs), being novel small-molecule chemical entities and its translation into kinetic energy for movement within the hydrophobic membrane core.Aposense was founded in 1996 and is headquartered in Petah Tiqva, HaMerkaz, Israel.
- MAKO Surgical — MAKO Surgical is a medical device company, markets its advanced robotic arm solution, joint specific applications for the knee and hip, and orthopedic implants for orthopedic procedures in the United States and internationally. The company offers MAKOplasty, a restorative surgical solution that enables orthopedic surgeons to treat patient specificosteoarthritic disease. It also provides robotic arm interactive orthopedic system (RIO) consisting of a tactile robotic arm utilizing an integrated bone cutting instrument; and a patient specific visualization component, which offers pre-operative and intra-operative guidance to the orthopedic surgeon, enabling tissue sparing bone removal, and accurate implant insertion and alignment.In 2011, The company was named the No.1 on the Technology Fast 500 as the fastest growing technology company by Deloitte and received the CSSEC Award for loyal, customer-focused staff members presented by the Technology Services Industry Association and ACE Award (Achievement in Customer Excellence) from MarketTools and Fast Tech Award as one of the 25 fastest growing technology companies in South Florida by South Florida Business Journal.MAKO Surgical was founded in 2004 and is headquartered in Florida, USA.
- MobileAccess Networks — Corning Everon Network Solutions offer in-building cellular solutions to meet a broad array of design scenarios and mitigate RF propagation challenges.
A15 is an entrepreneurial company that invests in digital products and technology brands. They aspire to empower the human race to overcome its limits and expand its capabilities by creating real products for real people. They help them scale by providing them with investment, the support of our ecosystem, and act as their launchpad for expansion.It was founded in 1996 and is headquartered in Cairo, Egypt.
Show more...Investment focus
- Industry: E-Commerce, FinTech, Software
- Stage:Seed, Venture - Series Unknown, Pre-Seed
- Geography: Egypt, United States, United Kingdom
Investor stats
- Total investments: 60
- Round size: Seed $100k–$8M; Pre-Seed $50k–$1.4M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iVoiceUp — iVoiceUp is the first whistleblowing platform in MENA for anonymous reporting, case management, and compliance analytics. Detect fraud, protect reporters, and build defensible compliance.
- Byit — Byit is a technology platform developed to empower independent real estate brokers and freelancers.
- KNOT Technologies — Sell tickets, merchandise, and hospitality in one place. With built-in fraud protection and real-time revenue tools, you stay in control at every step.
Good Company Fund is investing in early-stage companies that leverage deep technologies to solve the world’s biggest problems. The firm is constantly seeking bold entrepreneurs who are building frontier technology solutions. Good Company Fund is generally looking to invest in innovative, hyper scalable, software solutions. It is especially excitedabout: Future of Energy, Future of Work and Education, Future of Work, Circular Economy, Precision Farming, and Digital Health. However, it is constantly learning and looking for additional opportunities in other verticals and aiming to invest in the "Operating System of the New, Sustainable World".Good Company's studio brings together multinational corporations, entrepreneurs and capital, in order to solve the world’s biggest problems. Good Company Studio is a home for entrepreneurs who want to create businesses with a purpose. The Studio is a pre-seed platform that provides entrepreneurs with capital, network, go-to-market, mentoring, and support.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Recruiting
- Stage:Seed, Pre-Seed, Series A
- Geography: Israel, United States
Investor stats
- Total investments: 20
- Round size: Seed $700k–$22M; Pre-Seed $400k–$4.8M; Series A $5M–$17M
- Lead/follow: 20% lead, 80% follow
- Last fund: Likely still investing — raised $30M in 2023
Portfolio highlights
- Jotit — Jotit is a cutting-edge educational technology startup that uses handwriting tools to help kids, instructors, and parents stay organized.
- TULU — TULU is a smart platform and amenity services provider to over 10,000 people in 50 buildings across the United States, Europe and Israel. Founded in 2019, TULU provides urban tenants with on-demand access to hundreds of brand name appliances, grocery staples, micro-mobility and entertainment devices, and more. TULU’s IoT-based modular units arecustomized to provide the most necessary and useful items, while leveraging advanced machine learning tools to analyze behavioral patterns, optimize usage, refine inventory, and create a personalized experience for our users. The outcome is a new way of living, encouraging more responsible consumption, reducing the cost of living in the city, and consistent with the trend to smaller and smaller living spaces.
- Algocell — Optimize precision fermentation and cell culture bioprocesses using Digital Twin, AI and Hybrid Models. Create your first model now!
Leading Global Healthcare Platform with Deep Proprietary Resources and Global Industry Coverage.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Pharmaceutical
- Stage:Series B, Series A, Series C
- Geography: United States, China, Israel
Investor stats
- Total investments: 762
- Round size: Series A $9.8M–$116M; Series B $23M–$148M; Series C $19M–$160M
- Lead/follow: 36% lead, 64% follow
- Last fund: Likely actively investing — fresh fund, raised $192M in 2026
Portfolio highlights
- CoGenesys — CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. The company develops peptide and protein-based medicines for cancer, cardiovascular, metabolic, infectious, autoimmune, and CNS diseases.
- InventisBio — InventisBio is a biotech company whose product pipeline includes small molecule drug candidates for targeted therapies in lung cancer, breast cancer and gout. The company is also actively developing drugs that can be combined with other immune-oncology targeted therapies, such as PD-1 antibody, for various cancer indications. The company isco-founded by Dr. Yaolin Wang and other scientists who have previously worked at Merck and Schering-Plough, leading various drug discovery projects in oncology, metabolic and infectious disease areas.
- Bonovo Orthopedics —
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!GE Ventures combines capital, technical, and commercial services. They invest in the healthcare and life sciences, energy and mobility, manufacturing and supply chain, enterprise productivity applications, digital infrastructure, and frontier technologies sectors.
Show more...Investment focus
- Industry: Health Care, Software, Enterprise Software
- Stage:Series B, Series A, Series C
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 164
- Round size: Series A $6M–$32M; Series B $6M–$31M; Series C $14M–$70M
- Lead/follow: 24% lead, 76% follow
Portfolio highlights
- FogHorn — FogHorn is a developer of “edge intelligence” software for industrial and commercial IoT application solutions. FogHorn’s software platform brings the power of advanced analytics and machine learning to the on-premises edge environment enabling a new class of applications for advanced monitoring and diagnostics, machine performance optimization,proactive maintenance and operational intelligence use cases. FogHorn’s technology is ideally suited for OEMs, systems integrators and end customers in manufacturing, power and water, oil and gas, renewable energy, mining, transportation, healthcare, retail, as well as smart grid, smart city, smart building and connected vehicle applications.
- The Plate — Monetize your culinary talent. Publish your content and recipes, host workshops and build your community on The Plate.
- Catalant — Access on-demand consulting services for strategic business planning, data & business analytics, digital transformation, M&A, market research, and more.
ALIVE Israel HealthTech Fund is a pioneer mid-to-late stage HealthTech fund leveraging an exclusive ecosystem.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Series B, Series C
- Geography: Israel, United States
Investor stats
- Total investments: 16
- Round size: Series A $4.4M–$17M; Series B $22M–$30M; Series C $30M–$55M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely actively investing — fund raised in 2025
Portfolio highlights
- Navina — Navina uses medically-informed AI to replace disorganized patient data with an intuitive Patient Portrait - a logical grid that makes it possible for every primary care physician to assess even the most complex cases in minutes. Designed for and loved by physicians, Navina allows for high quality and empathic patient care, resulting in better treatment, reduced missed diagnoses and enhanced financial performance for providers and payers.
- UltraSight — UltraSight aims to revolutionize ultrasound through the power of machine learning to enable more accurate and timely clinical decisions. The UltraSight automated guidance system helps bring the benefits of cardiac imaging to healthcare professionals in new care settings, allowing patients access to ultrasound anywhere.
- Magenta Medical — Founded in October, 2012, Magenta Medical Ltd. is a privately held company that is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
Founded in 2015, Phoenician Funds is at the heart of thriving capitals of digital innovation and startup ecosystems in the Middle East and North Africa ...
Show more...Investment focus
- Industry: FinTech, Financial Services, Software
- Stage:Seed, Series A, Pre-Seed
- Geography: Lebanon, United Arab Emirates, Egypt
Investor stats
- Total investments: 25
- Round size: Seed $700k–$3M; Pre-Seed $50k–$1M; Series A $1.5M–$8.4M
- Lead/follow: 32% lead, 68% follow
- Last fund: May invest from a new fund soon — raised $30M in 2015
Portfolio highlights
- Go Rise — Go Rise is a start-up building a financial services platform for migrants.
- Ostaz — Ostaz is an education technology (EdTech) company focused on delivering AI-powered personalized tutoring services across the Middle East, particularly in the UAE, Saudi Arabia, and Lebanon. The platform connects students with qualified tutors while using artificial intelligence to improve tutor-student matching and educational outcomes.
- TWIG — TWIG is a Bank Agnostic Automated Savings Platform in the MENA region. Our flagship app provides Automated Saving Plans to help users save better; a Smart Budgeting tool with tailored insights; and Smart, customizable and user-specific Goals.
Shengjing Group offers businesses consulting services.
Show more...Investment focus
- Industry: Artificial Intelligence, Manufacturing, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: China, Israel, Malaysia
Investor stats
- Total investments: 48
- Round size: Seed $2M–$14M; Series A $2.2M–$120M; Series B $2.9M–$42M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- Mojie — Mojie is a technology company that engages in the research and development of optics and AI solutions, known for its extensive development of various core technologies. The company operates research and development offices and high-end manufacturing bases.
- Tanwei Xinlian — Tanwei Xinlian serves as a domestic provider of interconnection communication solutions, offering expertise and innovation in this field.
- Fengxun Biotech — Nantong Fengxun Bio is a medical testing service provider. Its primary business focus is on testing services, cell technology research and development, and human stem cell technology development and application, among other things.
Qure Ventures is venture capital firm under OurCrowd. Qure is led by successful digital health veterans with vast experience founding, growing, and exiting companies over the last 20+ years.Qure has established strategic partnerships with key stakeholders in consumer, provider, payer, as well as pharma domains - providing fast track access tomarket and clinical trial opportunities for portfolio companies.Qure is Israel's first exclusively focused digital health fund. The fund focuses predominantly on startups located in Israel, home to world's leading tech + digital health ecosystem. OurCrowd's global network, investment leadership and in-house medical expertise provide Qure with unparalleled deal access and robust diligence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Israel
Investor stats
- Total investments: 9
- Round size: Series A $8.8M–$20M; Series B $20M–$20M
- Lead/follow: 22% lead, 78% follow
Portfolio highlights
- CoreMap — CoreMap exists to improve patient outcomes by delivering advanced diagnostic technology to electrophysiologists and patients.
- Sweetch — Sweetch is the first behavioral science company to leverage AI & EI (emotional intelligence) through its digital therapeutics solutions. Its hyper-personalized precision engagement platform enables health ecosystem players to build continuous relationships and engage with every individual patient, at scale.
- Carevive Systems — Powered by real world patient experience data, Carevive builds cancer care management tools that improve patient quality of life and survival outcomes.
At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United States, Israel, Canada
Investor stats
- Total investments: 309
- Round size: Seed $150k–$5.3M; Series A $1.8M–$25M; Series B $1.8M–$75M
- Lead/follow: 29% lead, 71% follow
- Last fund: Likely still investing — raised $50M in 2023
Portfolio highlights
- CloudSEK — CloudSEK leverages contextual AI to predict and prevent cyber threats. Keep your organisation safe and secure.
- NovaTract Surgical — NovaTract Surgical is a development stage company, intends to develop medical devices to address the rapidly growing field of Single Incision Laparoscopic Surgery (SILS) and Natural Orifice Transluminal Endoscopic Surgery (NOTES). The company was incorporated in 2010 and is based in Guilford, Connecticut.
- Axerion Therapeutics — Axerion Therapeutics, Inc. is a private Connecticut-based biotechnology company focused on developing innovative therapeutics for neurological diseases and injuries with significant unmet medical need, including Alzheimer’s disease and spinal cord injury.Axerion was established in New Haven to develop and commercialize intellectual propertylicensed from Dr. Stephen Strittmatter’s laboratory at Yale University. Axerion’s proprietary technology platforms include blockers of ß-amyloid (Aß) oligomers binding to Prion Proteins (PrP) on the cell surface of neurons as a novel therapeutic target for Alzheimer’s disease and Nogo Receptor decoy protein for recovery of neurological function in spinal cord injury and other neurological diseases.
CE Ventures was established in 2015 to focus on investments in private technology companies located in Israel and the United States. It considers opportunities across a broad spectrum of industries, including technology, media, telecommunications and digital health and invests in a mixture of early and later-stage opportunities.
Show more...Investment focus
- Industry: Software, Analytics, Big Data
- Stage:Series B, Series A, Series C
- Geography: Israel, United States, India
Investor stats
- Total investments: 35
- Round size: Series A $4M–$7M; Series B $3.5M–$30M; Series C $10M–$40M
- Lead/follow: 34% lead, 66% follow
- Last fund: May invest from a new fund soon — raised $50M in 2016
Portfolio highlights
- DiA Imaging Analysis — DiA is the leading provider of FDA cleared and CE marked ultrasound AI solutions that make the use and analysis of ultrasound images smarter, faster and accessible to all. Our solutions address the main challenges ultrasound users face - manually capturing and visually analyzing ultrasound images.
- NirogStreet — NirogStreet is the best platform for Ayurveda doctors. Learn and Earn from top Ayurveda Experts and get authentic Ayurvedic medicines at the best deals.
- Centrical — Centrical helps businesses improve employee engagement, proficiency, and performance through gamification, microlearning, and performance management.
MTIP is a growth capital investor that specializes in scaling up healthtech companies in rapidly expanding global markets. Visit our website!
Show more...Investment focus
- Industry: Health Care, Medical, Artificial Intelligence
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Spain
Investor stats
- Total investments: 29
- Round size: Series A $1.5M–$36M; Series B $10M–$30M; Series C $9.3M–$80M
- Lead/follow: 59% lead, 41% follow
- Last fund: Likely still investing — raised $250M in 2021
Portfolio highlights
- TrialBee — Trialbee is revolutionizing clinical trials with innovative global patient recruitment solutions. Streamline your recruitment process today.
- Verifarma — Verifarma offers comprehensive, robust & high-quality services to drugs, medical products, chemical precursors, agrochemicals.
- NitiNotes — Nitinotes has developed the EndoZipTM, a fully automated, operator independent gastroscopic suturing system, allowing gastroenterologists as well as surgeons to bring a durable solution to their patients. The procedure creates an effect of stomach volume restriction and motility impair - both are needed to help obese patients reducing weight.
What is AUC Angels? AUC Angels is the first university-based angel investor network in the MENA region. Angel investors are individuals who are interested in investing in early-stage startups with growth potential which in turn supports the growth of a dynamic entrepreneurship ecosystem in Egypt.
Show more...Investment focus
- Industry: E-Commerce, Software, Retail
- Stage:Seed, Pre-Seed, Angel
- Geography: Egypt, United Kingdom, United States
Investor stats
- Total investments: 36
- Round size: Seed $100k–$1.2M; Angel $100k–$230k; Pre-Seed $40k–$200k
- Lead/follow: 39% lead, 61% follow
Portfolio highlights
- Roboost — Tayar is an enterprise solution using Artificial intelligence and complex Algorithms to facilitate, optimize, and manage the delivery process to any BTC (mainly home delivery) business to increase the delivery speed and performance.
- InCurA — Why InCurA ProductsWe Innovate Medical Devices for Today, Tomorrow and What's Needed NextInCurA is developing a pipeline of products based on its unique
- UNLOCK — Companies looking to outsource certain department functions should look no further than Unlock EPN. A complete and diverse business directory of agencies and companies in Egypt. All are available with direct contact information for your convenience.
We are a team of former serial founders managing $1.5Bn across a number of funds, with offices in Tel Aviv, London, and New York. We back the next generation of category-defining companies with conviction of founders who have built companies themselves.We back founders with a partnership built on trust, fairness and real operating experience. Westand with founders through every challenge, and help them grow with clarity, resilience and purpose.
Show more...Investment focus
- Industry: Software, FinTech, Financial Services
- Stage:Seed, Series A, Series B
- Geography: Israel, United States, United Kingdom
Investor stats
- Total investments: 309
- Round size: Seed $1.5M–$15M; Series A $5M–$30M; Series B $17M–$54M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely actively investing — fresh fund, raised $175M in 2025
Portfolio highlights
- Chamelio — Chamelio builds intelligent technology for in-house legal teams. We understand that every in-house legal team operates uniquely - shaped by their industry context, company culture, and strategic priorities. Our platform adapts to these distinct characteristics, delivering hyper-personalized workflows that evolve with your team's specific needs.
- Archy — SaaS Practice Management Software for Dental Practices
- Lasso Security — Lasso Security defends the LLM frontier with advanced LLM Cybersecurity solutions. Embrace progress and strengthen your AI cybersecurity posture
FAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in Middle East investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 48,091 VC funds investing in Middle East Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!